NCT00140244View on ClinicalTrials.gov

Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

HAART-induced Lipodystrophy and Metabolic Syndrome

Interventions

DRUG

r-metHuLeptin

DRUG

Placebo

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Amgen

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER